Welcome to the cacner Centre

 

 

Health Insite endorsed site

 

Breast Endocrine & Surgical Oncology

 

Associate Professor P Grantley Gill

Head Of Unit Breast, Endocrine & Surgical Oncology Unit,
Royal Adelaide Hospital.
Associate Professor Department of Surgery,
University Of Adelaide.
Surgical Coordinator BreastScreen South Australia.
COMMITTEES:
  • Medical Executive Committee - BreastScreen SA
  • Chair - Australasian Multicentre Study of Sentinel Node Biopsy Versus Axillary Clearance (The SNAC Trial)
  • State Accreditation Committee - BreastScreen SA
TEACHING/ACADEMIC:
  • Breast Lump Module - Problem based learning - University of Adelaide
  • Postgraduate Courses - Management of Early screen detected breast cancer (March, September 2003)
  • Clinical Tutorials for 4 th, 5 th, and 6 th Year Medical Students
CLINICAL RESEARCH PROJECTS
  • Australasian Multicentre Study of Sentinel Node Biopsy Versus Axillary Clearance (The SNAC Trial)
  • ANZ Breast Cancer Trial Group - BIG 1-98 Study
  • C-VAX Stage III & IV Study
  • BIG-98 trial (Adjuvant Letrozole versus Tamoxifen in ER positive breast cancer)
MEETINGS/COURSES ATTENDED:
  • Royal Australasian College of Surgeons Annual Scientific Meeting – Melb May 2005
  • Leura International Breast Conference –Invited Speaker - Sydney, November 2004
  • International Association of Pathologists – Invited Speaker - Brisbane, October 2004
  • International Sentinel Node Society – Invited Speaker - Los Angeles, December 2004
  • SNAC Investigators Meeting - Melbourne, May 2004
  • Royal Australasian College of Surgeons, State Branch, Annual Scientific Meeting September 2004
GRANTS:
  • NH&MRC – The SNAC Trial (continuing grant) $1.2 million over 5 years – Gill et all
  • National Breast Cancer Foundation $94,000 pa for 2004 and 2005 the SNAC Trial - Gill et al
  • Anti Cancer Council of South Australia $24,000 for 2004 – Gill P G., Kollias J., Bochner M.
CLINICAL RESEARCH PROJECTS:
  • Australasian Multicentre Study of Sentinel Node Biopsy Versus Axillary Clearance (The SNAC Trial)
  • ANZ Breast Cancer Trial Group-BIG 1-98 Study
  • C-VAX Stage III & IV Study
  • BIG-98 trial (Adjuvant Letrozole versus Tamoxifen in ER positive breast cancer)
PUBLICATIONS:
  • Detection by screening mammography is a powerful independent predictor of survival
  • in women diagnosed with breast cancer –P G Gill, G Farshid, C G Luke, D M Roder
  • Implication of intraoperative sentinel node imprint cytology for consent in the SNAC
  • Trial. ANZ J Surg, 74: 105-197 Bochner MA, Kollias J, Gill PG, Farshid G, Dodd TJ.
  • (2004)
  • Breast volume replacement using the latissimus dorsi miniflap. ANZ J Surg, 74: 98-
  • 104. Nano MT, Gill PG, Kollias J, Bochner M. (2004)
  • Sentinel Lymph Node dissection and lymphatic mapping for local subcutaneous
  • recurrence in melanoma treatment: longer-term follow-up results. Annals of Surgery.
  • Ann Surg Oncol, Mar-Apr; 11(3 Suppl): 203S-7S. Coventry BJ, Gill PG, Chatterton B.
  • (2004)
  • Sentinel Lymph Node biopsy versus axillary clearance in operable breast cancer:
  • The RACS SNAC Trial, A multicentre randomized trial of the Royal Australasian College
  • Surgeons (RACS Section of Breast Surgery, in collaboration with the National Health
  • & Medical Research Council Clinical Trails Center. Annals Surg Oncol, Mar-Apr;11(3 Supp): 216S-21S. Gill PG (2004)